Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1M Sell
26,366
-14,637
-36% -$9.74M 0.28% 50
2026
Q1
$22.3M Sell
41,003
-10,260
-20% -$4.18M 0.34% 42
2025
Q4
$16.2M Sell
51,263
-1,057
-2% -$335K 0.23% 70
2025
Q3
$14.2M Buy
52,320
+3,160
+6% +$724K 0.22% 71
2025
Q2
$10.8M Sell
49,160
-2,280
-4% -$411K 0.19% 79
2025
Q1
$6.75M Buy
51,440
+47
+0.1% +$6.56K 0.13% 95
2024
Q4
$7.04M Buy
51,393
+4,235
+9% +$582K 0.13% 91
2024
Q3
$4.78M Buy
+47,158
New +$3.73M 0.1% 96

Other funds holding AGX

Sapient Capital's AGX Position: Q2 2026 in Review

Sapient Capital reduced its Argan (AGX) stake by 36% in Q2 2026, selling an estimated $9.74M and leaving 26,366 shares worth $21.1M. The position accounts for 0.28% of the portfolio, ranked #50.

Sapient Capital first reported a position in AGX in Q3 2024 and has held it in 8 quarters since. The position peaked at $22.3M in Q1 2026. 563 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Sapient Capital held 26,366 shares of Argan worth $21.1M as of Q2 2026.
  • Sapient Capital sold 14,637 Argan shares in Q2 2026, an estimated $9.74M.
  • Argan made up 0.28% of Sapient Capital's portfolio in Q2 2026, its #50 holding.
  • Sapient Capital first reported a position in Argan in Q3 2024 and has held it in 8 quarters since.
  • Sapient Capital's Argan position peaked at $22.3M in Q1 2026.
  • 563 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.